CF PharmTech, founded in 2007, is a dynamic specialty pharmaceutical company focused on in- and out-licensing, contract development, and manufacturing products for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis for the global market。 Our mission is to provide high-quality, affordable medicine and effective management care for respiratory diseases。
Our facility is housed in two buildings covering approximately 15,700 m². The headquarters and factory of CF PharmTech are located in Suzhou, China. They contain a GMP QC lab, which has been designed to be compliant with U.S. Food & Drug Administration (FDA) rules and regulations, and four inhalation dosage form manufacturing lines including: Inhalation Aerosol, Inhalation Powder, BFS Products, and Nasal Spray.
All manufacturing lines can be compliant with both China GMP and US GMP.
This facility offers CF the ability to support our partners and clients worldwide from the early stages (formulation development, analytical method development, device selection, manufacturing, and stability study), to clinical development (clinical manufacturing), to market launch, and beyond。
1。 Project leaders with years of experience in both the global and Chinese markets。
2. Comprehensive GMP facility that is capable of manufacturing all forms of inhalation drugs and meet GMP requirements.
3. Competitive price and high standards that provide significant cost savings and high quality.